These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 16488400)
1. Multiple processing forms and their biological activities of a novel angiogenesis inhibitor vasohibin. Sonoda H; Ohta H; Watanabe K; Yamashita H; Kimura H; Sato Y Biochem Biophys Res Commun; 2006 Apr; 342(2):640-6. PubMed ID: 16488400 [TBL] [Abstract][Full Text] [Related]
2. The vasohibin family: a negative regulatory system of angiogenesis genetically programmed in endothelial cells. Sato Y; Sonoda H Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):37-41. PubMed ID: 17095714 [TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of vasohibin-2 as a homologue of VEGF-inducible endothelium-derived angiogenesis inhibitor vasohibin. Shibuya T; Watanabe K; Yamashita H; Shimizu K; Miyashita H; Abe M; Moriya T; Ohta H; Sonoda H; Shimosegawa T; Tabayashi K; Sato Y Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1051-7. PubMed ID: 16528006 [TBL] [Abstract][Full Text] [Related]
4. Alternative splicing of vasohibin-1 generates an inhibitor of endothelial cell proliferation, migration, and capillary tube formation. Kern J; Bauer M; Rychli K; Wojta J; Ritsch A; Gastl G; Gunsilius E; Untergasser G Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):478-84. PubMed ID: 18187668 [TBL] [Abstract][Full Text] [Related]
5. Isolation of a small vasohibin-binding protein (SVBP) and its role in vasohibin secretion. Suzuki Y; Kobayashi M; Miyashita H; Ohta H; Sonoda H; Sato Y J Cell Sci; 2010 Sep; 123(Pt 18):3094-101. PubMed ID: 20736312 [TBL] [Abstract][Full Text] [Related]
6. Expression pattern of Vasohibin during chick development. Nimmagadda S; Geetha-Loganathan P; Pröls F; Scaal M; Christ B; Huang R Dev Dyn; 2007 May; 236(5):1358-62. PubMed ID: 17394205 [TBL] [Abstract][Full Text] [Related]
7. Vasohibin prevents arterial neointimal formation through angiogenesis inhibition. Yamashita H; Abe M; Watanabe K; Shimizu K; Moriya T; Sato A; Satomi S; Ohta H; Sonoda H; Sato Y Biochem Biophys Res Commun; 2006 Jul; 345(3):919-25. PubMed ID: 16707096 [TBL] [Abstract][Full Text] [Related]
8. Processing in the C-terminal domain of minicollagen XII removes a heparin-binding site. Aubert-Foucher E; Goldschmidt D; Jaquinod M; Mazzorana M Biochem Biophys Res Commun; 2001 Sep; 286(5):1131-9. PubMed ID: 11527417 [TBL] [Abstract][Full Text] [Related]
9. Expression of vasohibin, an antiangiogenic factor, in human choroidal neovascular membranes. Wakusawa R; Abe T; Sato H; Yoshida M; Kunikata H; Sato Y; Nishida K Am J Ophthalmol; 2008 Aug; 146(2):235-243. PubMed ID: 18486097 [TBL] [Abstract][Full Text] [Related]
10. Is vasohibin-1 for more than angiogenesis inhibition? Sato Y J Biochem; 2011 Mar; 149(3):229-30. PubMed ID: 21217147 [TBL] [Abstract][Full Text] [Related]
11. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3). Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331 [TBL] [Abstract][Full Text] [Related]
13. Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis. Watanabe K; Hasegawa Y; Yamashita H; Shimizu K; Ding Y; Abe M; Ohta H; Imagawa K; Hojo K; Maki H; Sonoda H; Sato Y J Clin Invest; 2004 Oct; 114(7):898-907. PubMed ID: 15467828 [TBL] [Abstract][Full Text] [Related]
14. The vasohibin family: Novel regulators of angiogenesis. Sato Y Vascul Pharmacol; 2012; 56(5-6):262-6. PubMed ID: 22286022 [TBL] [Abstract][Full Text] [Related]
15. Expression of recombinant kringle 1-5 domains of human plasminogen by a prokaryote expression system. Hou WH; Fang T; Chai YR; Wang TY; Wang JM; Xue LX Protein Expr Purif; 2006 May; 47(1):93-8. PubMed ID: 16510293 [TBL] [Abstract][Full Text] [Related]
16. A double WAP domain (DWD)-containing protein with proteinase inhibitory activity in Chinese white shrimp, Fenneropenaeus chinensis. Du ZQ; Ren Q; Zhao XF; Wang JX Comp Biochem Physiol B Biochem Mol Biol; 2009 Oct; 154(2):203-10. PubMed ID: 19545640 [TBL] [Abstract][Full Text] [Related]
17. Generation and characterization of rabbit polyclonal antibodies against Vasohibin-2 for determination of its intracellular localization. Sun J; Tu M; Han B; Xue X; Zhang Y; Wei J; Chen J; Lu Z; An Y; Cai B; Lv N; Jiang K; Miao Y; Gao W Int J Oncol; 2013 Jul; 43(1):255-61. PubMed ID: 23615928 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of the mitogenic, angiogenic and tumorigenic activities of pleiotrophin by a synthetic peptide corresponding to its C-thrombospondin repeat-I domain. Hamma-Kourbali Y; Bernard-Pierrot I; Heroult M; Dalle S; Caruelle D; Milhiet PE; Fernig DG; Delbé J; Courty J J Cell Physiol; 2008 Jan; 214(1):250-9. PubMed ID: 17607711 [TBL] [Abstract][Full Text] [Related]
19. Folding, activity and targeting of mutated human cathepsin D that cannot be processed into the double-chain form. Follo C; Castino R; Nicotra G; Trincheri NF; Isidoro C Int J Biochem Cell Biol; 2007; 39(3):638-49. PubMed ID: 17188016 [TBL] [Abstract][Full Text] [Related]
20. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells. Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]